Celltrion sets fresh earnings record on newer biosimilars

Celltrion has turned in yet another record quarterly earnings report on growing sales of its newer biosimilar portfolio and improving manufacturing efficiency. According to the Korean biopharmaceutical company on Monday, it logged 1.4 trillion won ($950 million) in sales and 451.8 billion won in ope